Print ISSN:-2394-2789

Online ISSN:-2394-2797


Article Metrics

Downlaod Files


Article Access statistics

Viewed: 486

PDF Downloaded: 659

Reverse transcriptase inhibitors: Potential drug delivery combating COVID-19

Full Text PDF Share on Facebook Share on Twitter

Review Article

Author Details : S V Deshpande*, D P Mali

Volume : 7, Issue : 4, Year : 2020

Article Page : 161-165

Suggest article by email


As the development of any drug and that too antiviral drug always requires time, in this Corona virus pandemic no specific drugs have been approved for coronavirus disease 2019 (COVID-19) till date. Therefore, assessment, analysis and use of currently available antiviral drugs become a challenge for medical field for a timely response to the current pandemic. Here, we have tried review anti CoV-2 potencies of available reverse transcriptase antiviral drugs. Several clinical trials are going on worldwide on variety of options but no specific solution in the form of vaccine or drug developed.

Keywords: COVID 19, SARS, Remdesivir.

How to cite : Deshpande S V , Mali D P , Reverse transcriptase inhibitors: Potential drug delivery combating COVID-19. Int J Pharm Chem Anal 2020;7(4):161-165

Copyright © 2020 by author(s) and Int J Pharm Chem Anal. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (

Wiki in hindi